WHO clears malaria treatment designed for newborns and infants
Swati Sri April 25, 2026: The World Health Organisation (WHO), prequalified the first anti malaria treatment developed specifically for newborns and young infants
Drugs
Health
Health
Opinion
Research
Fake research papers fuelling AI algorithms, turning fiction into fact
HQ Team April 21, 2026: When a Swedish researcher named Almira Osmanovic Thunström invented a disease called “bixonimania” in early 2024, she expected
Health
Research
Governance through waiting rooms; how the state uses time as a tool of control
Healthquill Team and Bhartijay April 21, 2026: In 2011, sociologist Javier Auyero spent six months sitting in a welfare office in Buenos Aires.
Health
Research
WSU study reveals how endometriosis rewires the brain to amplify chronic pain
Swati Sri A Washington State University (WSU) study has uncovered the biological mechanism behind one of the most frustrating aspects of endometriosis: why
Health
Newly recognized Type-5 diabetes may be affecting 25 million people worldwide
Swati Sri April 15, 2026: The International Diabetes Federation (IDF) has officially recognized a distinct fifth type of diabetes known as Type 5
Drugs
Health
Pharma
Novartis AG to acquire Exellergy for $2 billion, expand allergy portfolio
Novartis AG will buy a US-based private biotech company, Excellergy, Inc, for $2 billion to expand its allergy portfolio.
Uncategorized
Genetic study finds how Kenya’s Turkana survive with almost no water
HQ Staff writer March 26, 2026: Deep in the sun-scorched lands of northern Kenya, where temperatures soar and water sources vanish for months
Drugs
Health
Pharma
Merck to buy Terns for $6.7 billion as Keytruda drug patent loss looms
Merck & Co will buy Terns Pharmaceuticals, Inc., a clinical-stage oncology company, for $6.7 billion to pocket an investigational drug to treat a
Drugs
Health
Pharma
Novo, United’s trial drug cuts sugar levels by 2.16%, weight loss of 9.8%
HQ Team March 25, 2026: Novo Nordisk A/S and United Laboratories International Holdings Limited (TUL) mid-stage trials, held in China, helped in reducing
Drugs
Medical
Pharma
Pfizer, Valneva’s experimental Lyme disease vaccine shows 70% efficacy
HQ Team March 25, 2026: Pfizer Inc. and France-based Valneva SE‘s investigational vaccine has shown 70% efficacy in preventing Lyme disease in individuals